Sherbrooke, Canada

Jean-Francois Larrivee

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Immune Biosolutions Inc. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Francois Larrivee. Retrieved from https://idiyas.com/inventor/jean-francois-larrivee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jean-Francois Larrivee - Innovative Inventor from Sherbrooke

Introduction: Jean-Francois Larrivee is a renowned inventor hailing from Sherbrooke, Canada, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jean-Francois Larrivee holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced robotics, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Jean-Francois Larrivee has worked with leading research institutions and technology companies to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Jean-Francois Larrivee has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Jean-Francois Larrivee's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…